Diabeter Centrum Amsterdam

What Diabeter Centrum Amsterdam does

Diabeter Centrum Amsterdam is a specialized treatment center for children and adults with Type 1 diabetes or hereditary forms of diabetes (MODY), established in September 2023 as a joint venture between Amsterdam UMC (the merged academic hospital of AMC and VUmc) and Diabeter (a specialized diabetes network founded in 2006 that treats more than 3,000 patients across five Dutch locations). The center operates from a single location at Louwesweg 6, 1066 EC Amsterdam, in the former Slotervaart Hospital building, with an 11-person multidisciplinary team including internists, pediatricians, diabetes nurses, dietitians, psychologists, and medical assistants. Patients access the center through referrals from general practitioners and medical specialists via the Zorgdomein digital platform, with a 24/7 emergency line for current patients.

The center's core technology stack centers on two proprietary products: CloudCare, a remote monitoring platform that integrates with a broad range of glucose sensors (FreeStyle Libre 2/3, Dexcom G6/G7, Guardian 3/4, Simplera Sync) and insulin pumps (Medtronic 780G, Omnipod Dash/5, Tandem t:slim, Medtrum Nano, including DIY closed-loop systems) to aggregate glucose data and alert the clinical team; and the DCA App, a patient-facing mobile application providing glucose heatmaps, estimated HbA1c, insulin therapy advice, and appointment scheduling. Around these, the center delivers comprehensive clinical services including diagnosis, treatment, education, dietary counseling, psychological support, scientific research participation (BREBAD, MARVEL, MyDiaMate studies), travel declarations, driver's license support, and school-based support programs for children with Type 1 diabetes.

The business model is fully reimbursed through the Dutch basic health insurance (basisverzekering), with contracts held across all major Dutch health insurers (Zilveren Kruis, VGZ, CZ, Menzis, DSW, Zorg en Zekerheid, ONVZ, ASR, Salland, Caresq/Eucare). Patients do not receive bills directly; costs are offset against the mandatory deductible (eigen risico, which does not apply to children under 18). The center is a non-profit healthcare provider and does not disclose revenue figures. Diabetes supplies are routed through partner Diabstore, which has separate insurance contracts. The center is registered with the Geschillencommissie Zorg Algemeen for dispute resolution and complies with AVG (Dutch GDPR) for data protection.

Name

Diabeter Centrum Amsterdam

Legal name

Diabeter Centrum Amsterdam

Website

https://diabetercentrumamsterdam.nl

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Diabeter Centrum Amsterdam is a specialized Type 1 diabetes treatment center in Amsterdam, established in September 2023 as a joint venture between Amsterdam UMC and Diabeter, serving children and adults with personalized care, proprietary CloudCare remote monitoring, and the DCA App, fully reimbursed via Dutch basic health insurance.

Ownership category

akta.pro rank

Product category

Specialized Diabetes Care Services

NAICS

Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Type 1 Diabetes Care (HLAKADAB)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Specialized diabetes care
• Type 1 diabetes treatment
• Continuous glucose monitoring
• Insulin pump therapy
• Diabetes education

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Insured Healthcare Services (Verzekerde Zorg): Diabeter Centrum Amsterdam provides fully reimbursed medical care through the basic health insurance (basisverzekering). The center has contracts with all major and small health insurers including Zilveren Kruis, VGZ, CZ, Menzis, DSW, Zorg en Zekerheid, ONVZ, ASR, Salland, and Caresq/Eucare. Costs are billed directly to the health insurer; patients receive no bill but costs are offset against their deductible (eigen risico). Blood tests are analyzed at IJsselland Ziekenhuis Capelle aan den IJssel.
2. Diabetes Supplies via Diabstore: The center partners with Diabstore for diabetes supplies including CGM sensors. Diabstore has contracts with health insurers and delivers materials directly to patients. Some insurers have a preferentiebeleid (preference policy) for insulin brands, which may affect which products are reimbursed.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Diabeter Centrum Amsterdam is a specialized treatment center for children and adults with Type 1 or hereditary forms of diabetes, established in September 2023 through a collaboration between Amsterdam UMC and Diabeter. The center delivers comprehensive multidisciplinary diabetes care including diagnosis, insulin therapy, nutritional counseling, psychological support, and patient education, supported by two proprietary technology products: the CloudCare remote patient monitoring platform and the DCA App for patient-facing data access and treatment guidance.

Product overview

Diabeter Centrum Amsterdam offers a unified diabetes care ecosystem built around two primary technology products — CloudCare and the DCA App — supported by a comprehensive range of clinical services. CloudCare is the remote patient monitoring platform that integrates with glucose sensors (FreeStyle Libre, Dexcom, Guardian), insulin pumps (Medtronic, Omnipod, Tandem), and blood glucose meters to aggregate and transmit data to the clinical team. The DCA App serves as the patient-facing portal, drawing on CloudCare data to display heatmaps, estimated HbA1c, insulin therapy advice, and appointment information. Around these core technology products, the center delivers integrated clinical services including diabetes diagnosis, insulin therapy, medication management, nutritional counseling, exercise planning, patient education (individual and group), scientific research participation (BREBAD, MARVEL, MyDiaMate studies), travel declaration issuance, driver's license support, school and pediatric support programs, and a patient advisory panel. All services are covered under basic health insurance with contracts across all Dutch health insurers.

Differentiator

Problem solved

Functional benefit

Brands

• DCA App: Personal diabetes app developed by Diabeter Centrum Amsterdam for patients to view health data, insulin therapy advice, glucose heatmaps, and scheduled appointments.
• CloudCare
• Diabeter Panel

Products and services

• CloudCare

Quantifiable outcome

• No waiting list for new Type 1 diabetes diagnoses
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and major.

• Amsterdam UMCcoreStrategic or Co-development Partner · 1 September 2023Amsterdam UMC (merged from AMC and VUmc in June 2018) and Diabeter established Diabeter Centrum Amsterdam in September 2023. The diabetes team from Amsterdam UMC transitioned to the new center, bringing academic medical expertise and research capabilities. Amsterdam UMC employs 16,000+ people and is home to researchers working on understanding diabetes causes and developing curative therapies.
• DiabetercoreStrategic or Co-development PartnerDiabeter is a specialized Type 1 diabetes treatment center founded in 2006, treating over 3,000 people with Type 1 diabetes across five Dutch locations. The Schiphol location transitioned to become Diabeter Centrum Amsterdam. Diabeter contributes specialized methodology, patient panels, and extensive Type 1 diabetes expertise.
• DiabstoremajorChannel Partner/ Reseller/ DistributorDiabstore is the preferred supplier for diabetes supplies including CGM sensors, insulin, and other diabetes materials. They have contracts with all health insurers for 2025, providing patients with convenient centralized ordering. Free educational booklet and plush toy Raffie for children with Type 1 diabetes included with orders.
• ZorgdomeinmajorTechnology or IntegrationZorgdomein is the digital referral platform used for referring patients from GPs and specialists to Diabeter Centrum Amsterdam. The platform enables digital submission of medical questionnaires and facilitates seamless information transfer between referring healthcare providers and the treatment center.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Joslin Diabetes Center: Harvard-affiliated specialty diabetes center in Boston, US, focused on T1D and T2D care, education, and research with multidisciplinary clinical teams; a global benchmark for specialized diabetes centers comparable in clinical depth and research orientation.
• Diabeter: Parent organization and operating partner of Diabeter Centrum Amsterdam; founded in 2006, treats 3,000+ T1D patients across five Dutch locations (Rotterdam, Schiphol, Groningen, Eindhoven, Deventer) using the same CloudCare remote monitoring model and specialized T1D methodology.
• Steno Diabetes Center: Specialized diabetes treatment and research center in Denmark (Copenhagen) operated under the Capital Region; provides multidisciplinary T1D care, education, and clinical research in a publicly reimbursed model — directly comparable to Diabeter Centrum Amsterdam's academic-clinical partnership structure.

Emerging players

• One Drop: Digital diabetes management platform combining a connected glucometer, app-based coaching, and predictive analytics; represents the consumer-facing, app-first approach to T1D/T2D self-management that competes with DCA App on patient engagement.
• mySugr (Roche): Digital diabetes self-management app (now part of Roche Diabetes Care) offering connected CGM logging, bolus advice, and coaching; competes with DCA App/CloudCare on the patient-facing digital experience layer, though without the in-person clinical care model.
• Glooko: Diabetes data management platform that integrates data from most major CGMs, pumps, and BG meters for clinicians and patients; directly overlaps with CloudCare's device integration and remote-monitoring functionality as a potential competitor or partner.
• Cecelia Health: Virtual diabetes care and coaching service delivered via telehealth to people with T1D and T2D; offers a scalable, remote alternative to the in-clinic multidisciplinary care model that Diabeter Centrum Amsterdam provides.

Broad incumbents

• Medtronic Diabetes: Global leader in insulin pumps (MiniMed 780G) and integrated CGM systems used by DCA patients; while a device vendor rather than a care provider, it shapes the device ecosystem that CloudCare integrates with and competes for clinical mindshare in T1D management.
• Dexcom: Leading continuous glucose monitoring manufacturer (Dexcom G6/G7) widely used by Diabeter Centrum Amsterdam patients via CloudCare integration; an upstream device incumbent whose product roadmap directly affects the center's clinical workflows and outcomes data.
• Vida Health: Virtual chronic condition management platform covering diabetes alongside hypertension, obesity, and mental health; competes in the same payer-sponsored virtual chronic care category and offers an enterprise-scale alternative to specialty diabetes clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Customer concentration

• YouTubeyoutube.com/@diabeter
• LinkedInlinkedin.com/company/diabeter-centrum-amsterdam
• Instagraminstagram.com/diabetercentrumamsterdam

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diabeter Centrum Amsterdam